EP0349242A2 — Therapeutic nucleosides
Assigned to Wellcome Foundation Ltd · Expires 1990-01-03 · 36y expired
What this patent protects
The present invention relates to 6-substituted purine carbocyclic nucleosides and their use in medical therapy particularly in the treatment and prophylaxis of HIV and HBV infections. Also provided are pharmaceutical formulations and processes for the preparation of compounds acc…
USPTO Abstract
The present invention relates to 6-substituted purine carbocyclic nucleosides and their use in medical therapy particularly in the treatment and prophylaxis of HIV and HBV infections. Also provided are pharmaceutical formulations and processes for the preparation of compounds according to the invention.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.